We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

239 hedge funds and large institutions have $1.55B invested in Editas Medicine in 2020 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 84 increasing their positions, 58 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $33.3M | Put options by funds: $14.3M

45% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 58

2% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 43

0% more funds holding

Funds holding: 238 → 239 (+1)

0.24% less ownership

Funds ownership: 88.82% → 88.57% (-0.24%)

4% less capital invested

Capital invested by funds: $1.61B → $1.55B (-$61M)

Holders
239
Holders Change
+1
Holders Change %
+0.42%
% of All Funds
4.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
84
Reduced
58
Closed
43
Calls
$33.3M
Puts
$14.3M
Net Calls
+$19M
Net Calls Change
-$15.2M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$102M
2
BlackRock
BlackRock
New York
+$16.6M
3
Goldman Sachs
Goldman Sachs
New York
+$7.05M
4
SOMRS
State of Michigan Retirement System
Michigan
+$6.39M
5
N
Nuveen
North Carolina
+$5.63M

Top Sellers

Rank Fund Capital Flow
1
CCM
CAAS Capital Management
New York
-$41.3M
2
APM
Avidity Partners Management
Texas
-$17.7M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$12.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.04M
5
State Street
State Street
Massachusetts
-$5.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
ABC
226
Associated Banc-Corp
Wisconsin
$2K – – –
JWA
227
JFS Wealth Advisors
Pennsylvania
$2K – – –
PAI
228
Pittenger & Anderson Inc
Nebraska
$2K +$749 +23 +44%
CFG
229
CKW Financial Group
Hawaii
$2K +$2.21K +68 New
IRC
230
Investors Research Corp
Georgia
$2K +$2.44K +75 New
BFEC
231
Benjamin F. Edwards & Company
Missouri
$1K – – –
CFD
232
Creative Financial Designs
Indiana
$1K – – –
LC
233
Lindbrook Capital
California
$1K – – –
TWA
234
TCI Wealth Advisors
Arizona
$1K +$195 +6 +30%
EI
235
Ellevest Inc
New York
$1K +$391 +12 +200%
QCG
236
Quadrant Capital Group
Ohio
$1K +$586 +18 New
ECM
237
Estabrook Capital Management
New York
$365 – – –
CCM
238
CAAS Capital Management
New York
– -$41.3M -1,396,053 Closed
APM
239
Avidity Partners Management
Texas
– -$17.7M -600,000 Closed
Viking Global Investors
240
Viking Global Investors
Connecticut
– -$12.2M -413,000 Closed
Janus Henderson Group
241
Janus Henderson Group
United Kingdom
– -$4.65M -157,238 Closed
TCM
242
Tekla Capital Management
Massachusetts
– -$3.85M -130,201 Closed
Tudor Investment Corp
243
Tudor Investment Corp
Connecticut
– -$3.79M -128,111 Closed
MIM
244
Monashee Investment Management
Massachusetts
– -$3.11M -105,000 Closed
Millennium Management
245
Millennium Management
New York
– -$2.97M -100,361 Closed
SM
246
SG3 Management
Puerto Rico
– -$2.85M -87,386 Closed
PCM
247
Pinz Capital Management
New York
– -$2.48M -83,700 Closed
LCM
248
Laurion Capital Management
New York
– -$1.07M -36,200 Closed
AIM
249
Aigen Investment Management
New York
– -$547K -18,495 Closed
BCM
250
Barometer Capital Management
Ontario, Canada
– -$311K -10,500 Closed
8 9
10
11 12

EDIT Hedge Fund Activity: Q3 2020 in Review

239 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2020, worth a combined $1.55B — down 3.8% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new EDIT positions and 43 closed out — a net gain of 1 holder — while 84 added to existing stakes and 58 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $102M. The largest seller was CAAS Capital Management, exiting entirely with an estimated $41.3M sold.

  • 239 institutional investors held Editas Medicine (EDIT) as of Q3 2020, up from 238 in Q2 2020.
  • Funds reported $1.55B of Editas Medicine stock for Q3 2020, down 3.8% quarter-over-quarter.
  • 44 funds opened new Editas Medicine positions in Q3 2020 and 43 closed out, a net change of +1 holder.
  • The largest Editas Medicine buyer in Q3 2020 was ARK Investment Management, an estimated $102M added.
  • The largest Editas Medicine seller in Q3 2020 was CAAS Capital Management, an estimated $41.3M sold.

Based on aggregated 13F filings for Q3 2020.